Skip to main content

ADVERTISEMENT

myocardial infarction

Original Contribution
06/08/2021
The objective of this study was to assess the clinical and angiographic outcomes of coronary intravascular lithotripsy use in an all-comers population with moderate-to-severely calcified coronary lesions
The objective of this study was to assess the clinical and angiographic outcomes of coronary intravascular lithotripsy use in an all-comers population with moderate-to-severely calcified coronary lesions
The objective of this study was...
06/08/2021
Journal of Invasive Cardiology
Real-World Experience of Coronary Intravascular Lithotripsy in an Asian Population: A Retrospective, Observational, Single-Center, All-Comers Registry
Original Research
06/01/2021
To assess the clinical and angiographic outcomes of coronary intravascular lithotripsy use in an all-comers population with moderate-to-severely calcified coronary lesions.
To assess the clinical and angiographic outcomes of coronary intravascular lithotripsy use in an all-comers population with moderate-to-severely calcified coronary lesions.
To assess the clinical and...
06/01/2021
Journal of Invasive Cardiology
Clinical Images
09/26/2018
There are limited data regarding the snuffbox approach. Our experience highlights the feasibility of snuffbox approach as the access route for primary PCI and recannulation of distal radial artery for staged PCI.
There are limited data regarding the snuffbox approach. Our experience highlights the feasibility of snuffbox approach as the access route for primary PCI and recannulation of distal radial artery for staged PCI.
There are limited data regarding...
09/26/2018
Journal of Invasive Cardiology
Original Contribution
02/25/2018
A group of 2899 patients with acute coronary syndromes was studied to compare the safety and efficacy of those with LMCA disease vs those without LMCA disease. The primary endpoints of independently adjudicated major adverse cardiovascular...
A group of 2899 patients with acute coronary syndromes was studied to compare the safety and efficacy of those with LMCA disease vs those without LMCA disease. The primary endpoints of independently adjudicated major adverse cardiovascular...
A group of 2899 patients with...
02/25/2018
Journal of Invasive Cardiology
Original Contribution
10/01/2016
Human immunodeficiency virus (HIV) seropositive individuals are predisposed to acute myocardial infarction (AMI). We sought to evaluate management strategies and outcomes of AMI in patients with HIV in the contemporary era.
Human immunodeficiency virus (HIV) seropositive individuals are predisposed to acute myocardial infarction (AMI). We sought to evaluate management strategies and outcomes of AMI in patients with HIV in the contemporary era.
Human immunodeficiency virus...
10/01/2016
Journal of Invasive Cardiology
Original Contribution
06/15/2015
Direct stenting (DS) is commonly used during percutaneous coronary intervention for acute myocardial infarction (AMI) to prevent distal embolization. We compare DS with conventional stenting (CS) in patients presenting with AMI in a...
Direct stenting (DS) is commonly used during percutaneous coronary intervention for acute myocardial infarction (AMI) to prevent distal embolization. We compare DS with conventional stenting (CS) in patients presenting with AMI in a...
Direct stenting (DS) is commonly...
06/15/2015
Journal of Invasive Cardiology
Case Report
02/02/2010

Amar R. Chadaga, MD, Jamil B. Dihu, MD, Timothy A. Sanborn, MD

Amar R. Chadaga, MD, Jamil B. Dihu, M...
Cardiogenic shock represents the most ominous challenge of acute myocardial infarction (AMI), with an incidence of 8–9% and a mortality rate approaching 50%. The majority of cases of cardiogenic shock are secondary to AMI complicated by left...
Cardiogenic shock represents the most ominous challenge of acute myocardial infarction (AMI), with an incidence of 8–9% and a mortality rate approaching 50%. The majority of cases of cardiogenic shock are secondary to AMI complicated by left...
Cardiogenic shock represents the...
02/02/2010
Vascular Disease Management